Skip to main content
. 2020 Aug 29;46:102472. doi: 10.1016/j.msard.2020.102472

Table 3.

The correlation between DMDs and the risk of hospitalization.

Hospitalized (n) Not hospitalized (n) P-Value
Rituximab 12 26 0.15
Natalizumab 0 2 0.40
Ocrelizumab 1 0 0.08
Fingolimod 1 3 1
DMF 0 2 0.40
Glatiramer Acetate 0 5 0.17
IFN Beta 1A SC 0 5 0.17
IFN Beta 1A IM 0 5 0.17
Azathioprin 1 0 0.08
No medication 2 0 0.012 fisher exact; 0.059
OTHER MEDICATIONS 0 3 FISHER ECAT; 0.56

DMF: dimethylformamide; IFN-β 1α IM: interferon-β 1α intramuscular; interferon-β 1α subcutaneous.